Latest Breaking News On - Thrombectomy system - Page 1 : comparemela.com

Endovascular Engineering Announces First Patient Enrolled in ENGULF Pivotal Trial with its Hēlo™ PE Thrombectomy System for the Treatment of Pulmonary Embolism

Endovascular Engineering Announces First Patient Enrolled in ENGULF Pivotal Trial with its Hēlo™ PE Thrombectomy System for the Treatment of Pulmonary Embolism
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMike rosenthalMalcolm fosterPrnewswire endovascular engineering incEndovascular engineering incInstitute for healthcare policy innovationUniversity of michiganCardiac catheterization labTennova turkey creek medical centerMedicine studyHealthcare policyEndovascular engineeringInvestigational useThrombectomy system

Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance

Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its first quarter ended December 31, 2023,.

New yorkUnited statesEden prairieGary maharajSurmodics incAbbott vascular incQuarter fiscalRecent businessEndovascular issuesLow profileThrombectomy systemMedical deviceVitro diagnosticsAbbott vascularCall todayPrivate securities litigation reform act

Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Fina

EDEN PRAIRIE, Minn. (BUSINESS WIRE) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its first quarter ended December 31, 2023, and updated its financial guidance for fiscal year ending Septemb.

New yorkUnited statesEden prairieGary maharajAbbott vascular incSurmodics incQuarter fiscalRecent businessEndovascular issuesLow profileThrombectomy systemMedical deviceVitro diagnosticsAbbott vascularCall todayPrivate securities litigation reform act

Surmodics Announces Successful Early Clinical Use of Pounce™ LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the Knee

Addition of a low-profile device to the Surmodics Pounce™ thrombectomy platform allows for efficient clot removal in peripheral arteries ranging from 2 mm to 4 mm, such as those found below the.

Eden prairieUnited statesLucas ferrer cardonaGary maharajElizabeth genoveseDrug administrationHospital of the university pennsylvaniaDell seton medical centerUniversity of texas hospital in austinExchange commissionSurmodics incLow profilePounce thrombectomyPounce thrombectomy systemTexas hospitalPounce system

Endovascular Engineering s Hēlo™ Thrombectomy System Receives IDE Approval to Start ENGULF Pivotal Trial for the Treatment of Pulmonary Embolism

/PRNewswire/ Endovascular Engineering ("E2"), a medical device company focused on the development and deployment of groundbreaking clot removal technologies.

United statesMike rosenthalAjay giriAndrew kleinEndovascular engineering incUniversity of pennsylvaniaDevice exemptionThrombectomy systemCardiac catheterization laboratoriesInterventional cardiologistPiedmont heart institutePiedmont hospitalEndovascular engineeringInvestigational use